• Danone: Another quarter focused on execution and delivery; 2021 guidance reiterated

    ソース: Nasdaq GlobeNewswire / 19 10 2021 00:33:44   America/Chicago


    2021 Third-Quarter Sales
    Press release – Paris, October 19, 2021

    Another quarter focused on execution and delivery
    2021 guidance reiterated

    • Net sales of €6,158m in the third quarter, up +3.8% on a like-for-like (LFL) basis, and +5.8% on a reported basis
    • Another quarter focused on execution and delivery:
      • All categories contributing to growth with sustained strong momentum in EDP, continued recovery
        in Specialized Nutrition and Waters
      • Higher inflation and supply chain pressure, greater focus on productivity and pricing initiatives
      • Local First implementation on track
    • 2021 guidance reiterated: return to profitable growth in H2, and FY recurring operating margin broadly in line with 2020
    • Capital market event to take place on March 8th, 2022

    Juergen Esser: Chief Financial Officer statement

    “Today’s results further underscore our progress to profitable growth. Our actions and focused delivery across all parts of the company ensured that all categories contributed to a solid performance this quarter.

    We see clear evidence of our brands’ strengths and relevance to the global health and wellness agenda. Our Essential Dairy and Plant-based business continued its strong momentum, particularly in Europe and North America, with market share gains on key platforms. Our Waters business, led by a strong performance in Europe, benefited from the improved out of home mobility. And our Specialized Nutrition business also saw good dynamics driven by Adult Nutrition and the return to growth of Infant Milk Formula in China.

    Like just about everyone across the sector and beyond, we see inflationary pressures across the board. What started as increased inflation on material costs evolved into widespread constraints impacting our supply chain in many parts of the world. That said, we are putting even greater focus on productivity and pricing actions to mitigate the impact on our performance, thus re-iterating our FY 2021 guidance.”

    I. 2021 THIRD-QUARTER SALES

    € million
    except %    		Q3
    2020    		Q3
    2021    		Reported changeLFL Sales GrowthVolume Growth9M
    2020    		9M
    2021    		Reported changeLFL Sales GrowthVolume Growth


    BY REPORTING ENTITY    		          
    EDP3,1083,269+5.2%+4.1%+0.6%9,6999,686-0.1%+3.5%+1.1%
    Specialized Nutrition1,6981,777+4.6%+2.9%-5.3%5,4415,294-2.7%-0.8%-4.6%
    Waters1,0151,112+9.6%+4.6%+2.4%2,8643,031+5.8%+4.5%-0.6%


    BY GEOGRAPHICAL AREA    		          
    Europe & Noram13,3343,498+4.9%+3.9%+0.6%10,15610,282+1.2%+2.5%+0.7%
    Rest of the World2,4862,660+7.0%+3.7%-2.1%7,8487,729-1.5%+2.2%-2.1%
               
    TOTAL5,8216,158+5.8%+3.8%-0.8%18,00418,011+0.0%+2.3%-0.9%

       1North America (Noram): United States and Canada
    In the third quarter of 2021, consolidated sales stood at €6.2 bn, up +3.8% on a like-for-like basis, led by +4.6% in value and -0.8% in volume. On a reported basis, sales increased by +5.8%, benefiting from a positive impact of exchange rate of +0.8%, notably reflecting the appreciation of the Chinese Renminbi, the Mexican Peso and the British Pound against the Euro while the US Dollar and other emerging currencies remained broadly stable versus last year. Reported sales also benefited from +0.7% organic contribution of hyperinflation geographies to growth, as well as a slightly positive scope effect of +0.3%, mainly resulting from the combined effects of the integration of Harmless Harvest and Follow Your Heart and the disposal of Vega.

    In terms of regional dynamics, strong growth was broad-based in the third quarter. Europe and North America sales were up +3.9% on a like-for-like basis, driven by the sustained momentum in EDP and the recovery of Waters in Europe. Sales in the Rest of the World increased by +3.7% on a like-for-like basis, notably led by the performance of Specialized Nutrition in China.

    Performance by reporting entity

    • ESSENTIAL DAIRY AND PLANT-BASED (EDP)

    Essential Dairy & Plant-based posted sales growth of +4.1% in Q3 2021 on a like-for-like basis, reflecting a +0.6% increase in volume and +3.5% in value. The Essential Dairy portfolio delivered solid growth, while Plant-based grew strong mid-single digits. By geographical area, EDP in Europe and Noram was up +4.3% on a like-for-like basis during the period. In Europe, Essential Dairy performance was again driven by the Probiotics and Protein platforms, led by Actimel and YoPro, that registered double-digit growth, and Activia that pursued its strong momentum in the UK and Germany. Alpro delivered another quarter of double-digit growth, notably led by the strong performance of the recently relaunched Oat range. In Noram, growth was led by the Yogurt and Coffee Creations segments, with Oikos, Two Good and Activia showing very strong growth and market share gains, and International Delight and Stok delivering double-digit growth. The performance of the Plant-based portfolio was impacted this quarter by supply and logistic disruptions hampering Danone’s ability to produce and serve customer demand. In the Rest of the World, Latam and Africa continued their sequential recovery, while dynamics continued to be soft in CIS, amid a remaining challenging macro-economic and sanitary environment.

    • SPECIALIZED NUTRITION

    Specialized Nutrition sales increased by +2.9% in Q3 2021 on a like-for-like basis, with a decrease of -5.3% in volume and an increase of +8.2% in value. Adult Nutrition delivered mid single-digit growth, led by China and other emerging platforms, growing double-digits, while Europe delivered another quarter of growth. By segment, both the Oral and Tube feeding platforms continue to grow, while the Healthy Ageing platform pursued its roll-out in South-East Asia and Africa. Infant Nutrition delivered moderate growth this quarter. As expected, growth was led by China which grew double digits with a broad-based contribution from all channels. Channels distributing domestic labels delivered another quarter of mid to high single-digit growth while International labels sold in cross-border e-commerce platforms kept posting steep double-digit growth. Cross-border indirect channels, which notably include Daigous and Friends & Family, were back to growth after having declined by approximately -60% in the same period last year. In Europe, sales were flat in a declining market, while in other regions, dynamics were soft due to phasing effects.

    • WATERS

    Waters sales increased by +4.6% in Q3 2021 on a like-for-like basis, led by volumes up +2.4% and value +2.1%. Europe delivered strong mid single-digit growth, sequentially closing the gap vs 2019 and registered broad-based market share gains with an excellent performance of evian, Volvic, Żywiec Zdrój and Font Vella. In the Rest of the World, Mizone’s sales declined low single digit this quarter, after three quarters of growth. While sell-in was temporarily impacted by local lockdowns and bad weather, execution remained solid, with continuing recruitment of new young consumers and resilient market shares. Latin America delivered double-digit growth, thanks to a return to mobility this summer, while Indonesia’s performance was still negatively impacted by strong restrictions linked to Covid-19, including the re-implementation of some local lockdowns over the summer.

    II. 2021 OUTLOOK AND GUIDANCE

    Macro-economic outlook
    Despite short-term uncertainties, a gradual reopening of economies is assumed to continue as vaccination programs are rolled out. Meanwhile, a broad-based acceleration of inflation in milk, ingredients, packaging and logistics is expected.

    2021 guidance reiterated
    Danone expects to return to profitable growth in H2, and FY recurring operating margin is expected to be broadly in line with 2020.

    III. SHARE BUYBACK

    On July 29, 2021, Danone announced the launch a share buyback program of up to €800m worth of shares in the second half of 2021. As of October 15, 2021, the Company had repurchased an aggregate market value of €673 million.

    IV. MAJOR DEVELOPMENTS OVER THE PERIOD

    Governance and leadership changes

    • July 29, 2021: As part of the transition initiated earlier this year on the company’s governance framework, Danone’s Board of Directors announced an overhaul of its composition, that will be completed by Danone’s 2023 Shareholders’ Meeting.

    • September 28, 2021: Danone announced the appointment of Laurent Sacchi as General Secretary, succeeding Bertrand Austruy, with effect from October 1st. Laurent Sacchi joined Danone’s Executive Committee, while maintaining his duties as Secretary to the Board of Directors.

    • October 19, 2021: Danone announced the appointment of Roberto Di Bernardini as Chief Human Resources Officer with effect from November 29th. Roberto Di Bernardini will join Danone’s Executive Committee.

    Major financial transactions

    • September 7, 2021: As part of the active management of its hybrid debt portfolio and taking advantage of favorable market conditions, Danone launched the partial refinancing of its €1.25 billion hybrid bond. On September 7, 2021, Danone successfully priced an issue of €500 million undated deeply subordinated notes, offering a fixed resettable coupon of 1%, with a first call date on 16 December 2026. On September 15, 2021, Danone announced the success of the tender offer on part of its €1.25 billion hybrid bond (bearing a 1.750% p.a. coupon and with a first call date on 23 March 2023), for a total amount of €500 million. The new €500 million notes were issued and the tender offer on existing bonds was settled on 16 September 2021.

    V. IFRS STANDARDS AND FINANCIAL INDICATORS NOT DEFINED IN IFRS

    IAS29: impact on reported data

    Danone has been applying IAS 29 in hyperinflation countries as defined in IFRS. Adoption of IAS 29 in these hyperinflationary countries requires its non-monetary assets and liabilities and its income statement to be restated to reflect the changes in the general pricing power of its functional currency, leading to a gain or loss on the net monetary position included in the net income. Moreover, its financial statements are converted into euros using the closing exchange rate of the relevant period.

       IAS29: impact on reported data
    € million except %    		Q3 2021
    Sales2.5
    Sales growth (%)+0,04%

    Breakdown by quarter of 9M 2021 sales after application of IAS 29
    9M 2021 sales correspond to the addition of:

    • Q3 2021 reported sales;
    • Q1 and Q2 2021 sales resulting from the application of IAS29 until September 30, 2021 to sales of entities of hyperinflation countries (application of the inflation rate until September 30, 2021 and translation into euros using September 30, 2021 closing rate) and provided in the table below for information (unaudited data).
       € millionQ1 20211Q2 20212Q3 20219M 2021
    EDP3,1583,2593,2699,686
    Specialized Nutrition1,7231,7951,7775,294
    Waters7931,1261,1123,031
         
    Total5,6746,1796,15818,011

    1 Results from the application of IAS29 until September 30, 2021 to Q1 sales of entities of hyperinflation countries.
    2 Results from the application of IAS29 until September 30, 2021 to Q2 sales of entities of hyperinflation countries.

    Financial indicators not defined in IFRS

    Due to rounding, the sum of values presented may differ from totals as reported. Such differences are not material.

    Like-for-like changes in sales, recurring operating income and recurring operating margin reflect Danone's organic performance and essentially exclude the impact of:

    • changes in consolidation scope, with indicators related to a given fiscal year calculated on the basis of previous-year scope, both previous-year and current-year scopes excluding entities in countries under hyperinflation according to IAS 29 during the previous year (as for Argentinian entities since January 1st, 2019);
    • changes in applicable accounting principles;
    • changes in exchange rates with both previous-year and current-year indicators calculated using the same exchange rates (the exchange rate used is a projected annual rate determined by Danone for the current year and applied to both previous and current years).

    Bridge from reported data to like-for-like data

    (€ million except %)Q3 2020Impact of changes
    in scope of consolidation     		Impact of changes in exchange rates and others, including IAS29Organic contribution from hyperinflation countriesLike-for-like growthQ3 2021
           
    Sales5,821+0.3%+0.9%+0.7%+3.8%6,158

    Recurring operating income is defined as Danone’s operating income excluding Other operating income and expenses. Other operating income and expenses comprise items that, because of their significant or unusual nature, cannot be viewed as inherent to Danone’s recurring activity and have limited predictive value, thus distorting the assessment of its recurring operating performance and its evolution. These mainly include:

    • capital gains and losses on disposals of fully consolidated companies;
    • impairment charges on intangible assets with indefinite useful lives;
    • costs related to strategic restructurings or transformation plans;
    • costs related to major external growth transactions;
    • costs related to major crisis and major litigations;
    • in connection with of IFRS 3 (Revised) and IAS 27 (Revised) relating to business combinations, (i) acquisition costs related to business combinations, (ii) revaluation profit or loss accounted for following a loss of control, and (iii) changes in earn-outs relating to business combinations and subsequent to acquisition date.

    Recurring operating margin is defined as Recurring operating income over Sales ratio.

    o o O o o

    FORWARD-LOOKING STATEMENTS

    This press release contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward-looking statements by forward-looking words, such as “estimate”, “expect”, “anticipate”, “project”, “plan”, “intend”, “objective”, “believe”, “forecast”, “guidance”, “foresee”, “likely”, “may”, “should”, “goal”, “target”, “might”, “will”, “could”, “predict”, “continue”, “convinced” and “confident,” the negative or plural of these words and other comparable terminology. Forward looking statements in this document include, but are not limited to, predictions of future activities, operations, direction, performance and results of Danone.

    Although Danone believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of these risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Universal Registration Document (the current version of which is available at www.danone.com).

    Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell, or a solicitation of an offer to buy Danone securities.

    The presentation to analysts and investors will be broadcast live today from 9:00 a.m. (Paris time)
    on Danone’s website (www.danone.com).
    Related slides will also be available on the website in the Investors section.


    APPENDIX – Sales by reporting entity and by geographical area (in € million)

     First quarterSecond quarterThird quarter
     202020212020202120202021
    BY REPORTING ENTITY             
    EDP3,3643,1493,2383,2543,1083,269
    Specialized Nutrition1,9491,7191,7921,7931,6981,777
    Waters9287909251,1251,0151,112
    BY GEOGRAPHICAL AREA             
    Europe & Noram13,4693,2733,3523,5103,3343,498
    Rest of the World2,7722,3842,6022,6612,4862,660
                  
    Total6,2425,6575,9546,1715,8216,158


     First quarter
    2021    		Second quarter 2021Third quarter
    2021
     Reported changeLike-for-like changeReported changeLike-for-like changeReported changeLike-for-like change
    BY REPORTING ENTITY             
    EDP-6.4%+1.6%+0.5%+4.8%+5.2%+4.1%
    Specialized Nutrition-11.8%-7.7%+0.1%+2.8%+4.6%+2.9%
    Waters-14.9%-11.6%+21.6%+19.5%+9.6%+4.6%
    BY GEOGRAPHICAL AREA             
    Europe & Noram1-5.6%-2.8%+4.7%+6.4%+4.9%+3.9%
    Rest of the World-14.0%-4.2%+2.3%+6.9%+7.0%+3.7%
                  
    Total-9.4%-3.3%+3.6%+6.6%+5.8%+3.8%

    1North America (Noram): United States and Canada

    Attachment


シェアする